WallStreetZenWallStreetZen

NASDAQ: ORMP
Oramed Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Oramed Pharmaceuticals earnings were $64.1M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest ORMP earnings report on Dec 31, 2025 announced Q4 2025 earnings of $10.0M, down 79.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ORMP reported annual earnings of $64.1M, with -436% growth.

ORMP past earnings growth

How has ORMP's earnings growth performed historically?

Company
N/A
Industry
82.95%
Market
86.97%
ORMP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ORMP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

ORMP earnings history

Current Revenue
$2.0M
Current Earnings
$64.1M
Current Profit Margin
3,202.5%

ORMP Return on Equity

Current Company
36.7%
Current Industry
-30.5%
Current Market
28.9%
ORMP's Return on Equity (36.7%)... subscribe to Premium to read more.
High Return on Equity Performance

ORMP Return on Assets

Current Company
33.7%
Current Industry
-9.2%
ORMP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ORMP announces earnings.

ORMP Return on Capital Employed

Current Company
35.58%
Current Industry
-3.2%
ORMP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ORMP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ORMP$75.48M$64.05M+230.58%$1.53
SPRO$8.83M$8.57M-40.94%$0.15
PMN-$39.72M-$39.72MN/A-$22.61
FATE-$123.41M-$136.32MN/A-$1.15
ANTX-$35.17M-$35.17MN/A-$1.16
View Top Biotech Stocks

Oramed Pharmaceuticals Earnings Reports & History FAQ

What were Oramed Pharmaceuticals's earnings last quarter?

On ORMP's earnings call on Invalid Date, Oramed Pharmaceuticals (NASDAQ: ORMP) reported Q4 2025 earnings per share (EPS) of $0.23, up 188.46% year over year. Total ORMP earnings for the quarter were $10.01 million. In the same quarter last year, Oramed Pharmaceuticals's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Oramed Pharmaceuticals stock.

Is Oramed Pharmaceuticals profitable or losing money?

As of the last Oramed Pharmaceuticals earnings report, Oramed Pharmaceuticals is currently profitable. Oramed Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $64.05 million, a 436.04% decrease year over year.

What was ORMP's earnings growth in the past year?

As of Oramed Pharmaceuticals's earnings date in Invalid Date, Oramed Pharmaceuticals's earnings has grown year over year. ORMP earnings in the past year totalled $64.05 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.